Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Top Cited Papers
Open Access
- 21 December 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 12 (1), 62-76
- https://doi.org/10.1208/s12249-010-9563-0
Abstract
Lipid nanoparticles based on solid matrix have emerged as potential drug carriers to improve gastrointestinal (GI) absorption and oral bioavailability of several drugs, especially lipophilic compounds. These formulations may also be used for sustained drug release. Solid lipid nanoparticle (SLN) and the newer generation lipid nanoparticle, nanostructured lipid carrier (NLC), have been studied for their capability as oral drug carriers. Biodegradable, biocompatible, and physiological lipids are generally used to prepare these nanoparticles. Hence, toxicity problems related with the polymeric nanoparticles can be minimized. Furthermore, stability of the formulations might increase than other liquid nano-carriers due to the solid matrix of these lipid nanoparticles. These nanoparticles can be produced by different formulation techniques. Scaling up of the production process from lab scale to industrial scale can be easily achieved. Reasonably high drug encapsulation efficiency of the nanoparticles was documented. Oral absorption and bioavailability of several drugs were improved after oral administration of the drug-loaded SLNs or NLCs. In this review, pros and cons, different formulation and characterization techniques, drug incorporation models, GI absorption and oral bioavailability enhancement mechanisms, stability and storage condition of the formulations, and recent advances in oral delivery of the lipid nanoparticles based on solid matrix will be discussed.Keywords
This publication has 108 references indexed in Scilit:
- Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluationInternational Journal of Nanomedicine, 2010
- Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticlesJournal of Liposome Research, 2010
- Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid NanoparticlesAAPS PharmSciTech, 2010
- Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailabilityJournal of Liposome Research, 2009
- Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymersInternational Journal of Nanomedicine, 2008
- Visualizing the Structure of Triglyceride Nanoparticles in Different Crystal ModificationsLangmuir, 2007
- Nanosuspension Formulations for Low-Soluble Drugs: Pharmacokinetic Evaluation Using Spironolactone as Model CompoundDrug Development and Industrial Pharmacy, 2005
- Regional‐Dependent Intestinal Absorption and Meal Composition Effects on Systemic Availability of LY303366, a Lipopeptide Antifungal Agent, in DogsJournal of Pharmaceutical Sciences, 2001
- Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacological Research, 2000
- Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInternational Journal of Pharmaceutics, 1998